ZEGALOGUE

This brand name is authorized in Estonia, Lithuania.

Active ingredients

The drug ZEGALOGUE contains one active pharmaceutical ingredient (API):

1	Dasiglucagon UNII YQX12245A9 - DASIGLUCAGON HYDROCHLORIDE
	Dasiglucagon is a glucagon receptor agonist analogue, which increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver. Hepatic stores of glycogen are necessary for dasiglucagon to produce an antihypoglycaemic effect.
	Read more about Dasiglucagon

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZEGALOGUE Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H04AA02		H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones
Discover more medicines within H04AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3084836, 3084847, 3084858, 3084869
LT	Valstybinė vaistų kontrolės tarnyba	1100602, 1100603, 1100604, 1100605